Personalized Medicine Biomarkers Market (2025 - 2030) Size, Share & Trends Analysis Report By Application (Early Detection, Treatment Selection, Monitoring), By Indication (Oncology, Neurology), By Region, And Segment Forecasts
- Report Summary
- Table of Contents
- Interactive Charts
- Methodology
- Download FREE Sample
-
Download Sample Report
Market Segmentation
- Personalized Medicine Biomarkers Application Outlook (Revenue, USD Million, 2018 - 2030)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Personalized Medicine Biomarkers Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Personalized Medicine Biomarkers Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- North America Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- U.S.
- U.S. Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- U.S. Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- U.S. Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Canada
- Canada Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Canada Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Canada Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Mexico
- Mexico Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Mexico Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Mexico Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- North America Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Europe
- Europe Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Europe Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- UK
- UK Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- UK Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- UK Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Germany
- Germany Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Germany Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Germany Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- France
- France Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- France Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- France Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Italy
- Italy Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Italy Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Italy Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Spain
- Spain Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Spain Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Spain Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Europe Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Asia Pacific
- Asia Pacific Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Asia Pacific Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Japan
- Japan Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Japan Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Japan Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- China
- China Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- China Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- China Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- India
- India Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- India Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- India Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Australia
- Australia Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Australia Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Australia Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- South Korea
- South Korea Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- South Korea Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- South Korea Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Asia Pacific Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Latin America
- Latin America Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Latin America Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Brazil
- Brazil Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Brazil Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Brazil Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Argentina
- Argentina Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Argentina Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Argentina Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Latin America Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- MEA
- MEA Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- MEA Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- South Africa
- South Africa Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- South Africa Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- South Africa Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Saudi Arabia
- Saudi Arabia Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Saudi Arabia Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Saudi Arabia Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- UAE
- UAE Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- UAE Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- UAE Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Kuwait
- Kuwait Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Kuwait Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Kuwait Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- MEA Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
Get Free Sample Report
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
